spacer
home > pmps > summer 2017 > track your progress
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Track Your Progress

While serialisation in the pharmaceutical supply chain is generally regarded as inevitable – counterfeiting is simply too large of a problem to not be addressed – some uncertainty around the specifics exists, particularly from a global position. Regulations are advancing at various speeds around the world, and, to date, global standards as to how serial numbers should be formatted have not emerged.

Progressing Through Uncertainty

This has demanded that manufacturers move forward cautiously in their approach to serialisation. They must take steps to prepare without committing themselves to technologies that may not support future requirements. To that end, many have placed systems necessary to apply and capture serialisation data in their packaging processes, but have, in general, not addressed the impact of tracking these numbers across the supply chain.

This is partly due to the nature of a typical pharma supply chain, which is more dependent on third-party logistics providers for downstream processes than other industries. These providers enable companies to minimise supply chain assets and focus their capital on R&D, but they tend to limit their investments in automation because short-term contracts do not allow a return on investment within the contract period.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Michiel Veenman, Global Market Leader at Swisslog Warehouse and Distribution Solutions, has worked with various pharma companies to design advanced intralogistics solutions prior to taking on his current role. As such, he is responsible for continuously improving the company’s contribution to the market. This includes market research, organisational development and training and solution design, as well as systems support. Having studied logistics, Michiel has experience working for the Dutch Department of Defense and in automation system simulation and analysis. Before joining Swisslog, he spent five years optimising warehouse operations and IT systems for a small veterinarian pharma wholesaler.
spacer
Michiel Veenman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Staffordshire company Woolcool wins 2018 Queen’s Award for Innovation

The world is crying out for genuinely sustainable alternatives to manmade plastic packaging, so the winning of a Queen’s Award for Enterprise in Innovation by Staffordshire company Woolcool demonstrates the very real credibility of using a natural, renewable packaging resource – sheeps wool. First conceived by founder and CEO Angela Morris in 2001, Woolcool is a superior insulated packaging solution for the transportation of temperature-sensitive goods for the food and pharmaceutical sectors.
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

3rd PDA Europe Annual Meeting

26-27 June 2018, Berlin Marriott Hotel

The ongoing theme of the European Annual Meeting is Global Healthcare of the Present & the Future, as it intends to continue spanning a bridge between current demands within the global healthcare industry, the amounting advanced technological and analytical opportunities and the promising prospects personalized medicine and medicinal products bring.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement